Coronavirus latest news: EU Commission 'not to renew' AstraZeneca and Johnson & Johnson contracts
The move was reported by Italian daily La Stampaon Wednesday, which cited a source from the Italian Health Ministry.
“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.
It added that Brussels would rather focus on Covid-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer’s and Moderna’s.
A spokesman for the EU Commission said it was keeping all options open to be prepared for the next stages of the pandemic, for 2022 and beyond.
It comes as Denmark announced it would stop administering Oxford/AstraZeneca's Covid-19 vaccine following its possible link to very rare cases of blood clots, several Danish media outlets reported, citing unnamed sources.
The decision, which would remove the shot from Denmark's vaccination scheme, could delay the country's vaccine rollout by up to four weeks, based on previous statements by health bodies.